BEIJING, Jan. 15 (Xinhua) -- The inactivated vaccine developed by China National Biotec Group (CNBG) affiliated with Sinopharm is broad-spectrum and can cross-neutralize different coronavirus strains, CNBG chairman Yang Xiaoming told Xinhua in a recent interview.
"Tests for the mutant strains found in Britain are in progress, and the preliminary results are good. It (the vaccine) can induce protection," said Yang.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
